|Articles|November 1, 2012
- BioPharm International-11-01-2012
- Volume 25
- Issue 11
BioPharm International, November 2012 Issue (PDF)
Biosimilars : New Guidelines Set for Monoclonal Antibodies
Advertisement
Articles in this issue
almost 13 years ago
The Transformation to Process-Centered Organizationalmost 13 years ago
Considerations for Scale-Up of Stem-Cell Culturesalmost 13 years ago
Creating a Holistic Procurement Systemalmost 13 years ago
Product Characterization: A Primeralmost 13 years ago
A 25-Year Retrospective on Protein Recovery through Membrane Filtersalmost 13 years ago
Assay Development and Method Validation Essentialsalmost 13 years ago
Discovery Pipeline: Improved Delivery of RNA Vaccinesalmost 13 years ago
How to Manage Effective Leadership when Change is the Only Constantalmost 13 years ago
Product Analysis Key to Biosimilar DevelopmentNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
Analytics, Automation, and Quality Driving the Next Era of Drug Development
4
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
5
